53 research outputs found
Purification of the lysosomal sialic acid transporter. Functional characteristics of a monocarboxylate transporter
Sialic acid and glucuronic acid are monocarboxylated monosaccharides,
which are normally present in sugar side chains of glycoproteins,
glycolipids, and glycosaminoglycans. After degradation of these compounds
in lysosomes, the free monosaccharides are released from the lysosome by a
specific membrane transport system. This transport system is deficient in
the human hereditary lysosomal sialic acid storage diseases (Salla disease
and infantile sialic acid storage disease, OMIM 269920). The lysosomal
sialic acid transporter from rat liver has now been purified to apparent
homogeneity in a reconstitutively active form by a combination of
hydroxyapatite, lectin, and ion exchange chromatography. A 57-kDa protein
correlated with transport activity. The transporter recognized
structurally different types of acidic monosaccharides, like sialic acid,
glucuronic acid, and iduronic acid. Transport of glucuronic acid was
inhibited by a number of aliphatic monocarboxylates (i.e. lactate
A case of split notochord syndrome: a child with a neuroenteric fistula presenting with meningitis
The authors describe a case of split notochord syndrome with a neuroenteric fistula in a newborn presenting with meningitis. Associated anomalies included agenesis of the corpus callosum, short colon, malrotation, epispadias, and an abnormally high bifurcation of the abdominal aorta and inferior vena cava. The embryological mechanisms and etiologic theories are discussed in short
Subcortical heterotopic gray matter brain malformations: Classification study of 107 individuals
OBJECTIVE: To better evaluate the imaging spectrum of subcortical heterotopic gray matter brain malformations (subcortical heterotopia [SUBH]), we systematically reviewed neuroimaging and clinical data of 107 affected individuals. METHODS: SUBH is defined as heterotopic gray matter, located within the white matter between the cortex and lateral ventricles. Four large brain malformation databases were searched for individuals with these malformations; data on imaging, clinical outcomes, and results of molecular testing were systematically reviewed and integrated with all previously published subtypes to create a single classification system. RESULTS: Review of the databases revealed 107 patients with SUBH, the large majority scanned during childhood (84%), including more than half before 4 years (59%). Although most individuals had cognitive or motor disability, 19% had normal development. Epilepsy was documented in 69%. Additional brain malformations were common and included abnormalities of the corpus callosum (65/102 [64%]), and, often, brainstem or cerebellum (47/106 [44%]). Extent of the heterotopic gray matter brain malformations (unilateral or bilateral) did not influence the presence or age at onset of seizures. Although genetic testing was not systematically performed in this group, the sporadic occurrence and frequent asymmetry suggests either postzygotic mutations or prenatal disruptive events. Several rare, bilateral forms are caused by mutations i
Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice
Slc17a5−/− mice represent an animal model for the infantile form of sialic acid storage disease (SASD). We analyzed genetic and histological time-course expression of myelin and oligodendrocyte (OL) lineage markers in different parts of the CNS, and related this to postnatal neurobehavioral development in these mice. Sialin-deficient mice display a distinct spatiotemporal pattern of sialic acid storage, CNS hypomyelination and leukoencephalopathy. Whereas few genes are differentially expressed in the perinatal stage (p0), microarray analysis revealed increased differential gene expression in later postnatal stages (p10–p18). This included progressive upregulation of neuroinflammatory genes, as well as continuous down-regulation of genes that encode myelin constituents and typical OL lineage markers. Age-related histopathological analysis indicates that initial myelination occurs normally in hindbrain regions, but progression to more frontal areas is affected in Slc17a5−/− mice. This course of progressive leukoencephalopathy and CNS hypomyelination delays neurobehavioral development in sialin-deficient mice. Slc17a5−/− mice successfully achieve early neurobehavioral milestones, but exhibit progressive delay of later-stage sensory and motor milestones. The present findings may contribute to further understanding of the processes of CNS myelination as well as help to develop therapeutic strategies for SASD and other myelination disorders
Distinctive phenotypic abnormalities associated with submicroscopic 21q22 deletion including DYRK1A
Partial monosomy 21 has been reported, but the phenotypes described are variable with location and size of the deletion. We present 2 patients with a partially overlapping microdeletion of 21q22 and a striking phenotypic resemblance. They both presented with severe psychomotor delay, behavioral problems, no speech, microcephaly, feeding problems with frequent regurgi
Definitions and classification of malformations of cortical development: Practical guidelines
Malformations of cortical development are a group of rare disorders commonly manifesting with developmental delay, cerebral palsy
or seizures. The neurological outcome is extremely variable depending on the type, extent and severity of the malformation and the
involved genetic pathways of brain development. Neuroimaging plays an essential role in the diagnosis of these malformations, but several issues regarding malformations of cortical development definitions and classification remain unclear. The purpose of this consensus
statement is to provide standardized malformations of cortical development terminology and classification for neuroradiological pattern
interpretation. A committee of international experts in paediatric neuroradiology prepared systematic literature reviews and formulated
neuroimaging recommendations in collaboration with geneticists, paediatric neurologists and pathologists during consensus meetings in
the context of the European Network Neuro-MIG initiative on Brain Malformations (https://www.neuro-mig.org/). Malformations of
cortical development neuroimaging features and practical recommendations are provided to aid both expert and non-expert radiologists
and neurologists who may encounter patients with malformations of cortical development in their practice, with the aim of improving
malformations of cortical development diagnosis and imaging interpretation worldwide
Human mutations in integrator complex subunits link transcriptome integrity to brain development
Integrator is an RNA polymerase II (RNAPII)-associated complex that was recently identified to have a broad role in both RNA processing and transcription regulation. Importantly, its role in human development and disease is so far largely unexplored. Here, we provide evidence that biallelic Integrator Complex Subunit 1 (INTS1) and Subunit 8 (INTS8) gene mutations are associated with rare recessive human neurodevelopmental syndromes. Three unrelated individuals of Dutch ancestry showed the same homozygous truncating INTS1 mutation. Three siblings harboured compound heterozygous INTS8 mutations. Shared features by these six individuals are severe neurodevelopmental delay and a distinctive appearance. The INTS8 family in addition presented with neuronal migration defects (periventricular nodular heterotopia). We show that the first INTS8 mutation, a nine base-pair deletion, leads to a protein that disrupts INT complex stability, while the second missense mutation introduces an alternative splice site leading to an unstable messenger. Cells from patients with INTS8 mutations show increased levels of unprocessed UsnRNA, compatible with the INT function in the 3’-end maturation of UsnRNA, and display significant disruptions in gene expression and RNA processing. Finally, the introduction of the INTS8 deletion mutation in P19 cells using genome editing alters gene expression throughout the course of retinoic acid-induced neural differentiation. Altogether, our results confirm the essential role of Integrator to transcriptome integrity and point to the requirement of the Integrator complex in human brain development
Relations between the milnor and quillen K-theory of fields
De novo mutations in specific mTOR pathway genes cause brain overgrowth in the context of intellectual disability (ID). By analyzing 101 mMTOR-related genes in a large ID patient cohort and two independent population cohorts, we show that these genes modulate brain growth in health and disease. We report the mTOR activator gene RHEB as an ID gene that is associated with megalencephaly when mutated. Functional testing of mutant RHEB in vertebrate animal models indicates pathway hyperactivation with a concomitant increase in cell and head size, aberrant neuronal migration, and induction of seizures, concordant with the human phenotype. This study reveals that tight control of brain volume is exerted through a large community of mTOR-related genes. Human brain volume can be altered, by either rare disruptive events causing hyperactivation of the pathway, or through the collective effects of common alleles
The Phenotypic Spectrum of PNKP-Associated Disease and the Absence of Immunodeficiency and Cancer Predisposition in a Dutch Cohort
Background: We aimed to expand the number of currently known pathogenic PNKP mutations, to study
the phenotypic spectrum, including radiological characteristics and genotype-phenotype correlations,
and to assess whether immunodeficiency and increased cancer risk are part of the DNA repair disorder
caused by mutations in the PNKP gene.
Methods: We evaluated nine patients with PNKP mutations. A neurological history and examination was
obtained. All patients had undergone neuroimaging and genetic testing as part of the prior diagnostic
process. Laboratory measurements included potential biomarkers, and, in the context of a DNA repair
disorder, we performed a detailed immunologic evaluation, including B cell repertoire analysis.
Results: We identified three new mutations in the PNKP gene and confirm the phenotypic spectrum of
PNKP-associated disease, ranging from microcephaly, seizures, and developmental delay to ataxia with
oculomotor apraxia type 4. Irrespective of the phenotype, alpha-fetoprotein is a biochemical marker and
increases with age and progression of the disease. On neuroimaging, (progressive) cerebellar atrophy was
a universal feature. No clinical signs of immunodeficiency were present, and immunologic assessment
was unremarkable. One patient developed cancer, but this was attributed to a concurrent von HippelLindau mutation.
Conclusions: Immunodeficiency and cancer predisposition do not appear to be part of PNKP-associated
disease, contrasting many other DNA repair disorders. Furthermore, our study illustrates that the previously described syndromes microcephaly, seizures, and developmental delay, and ataxia with oculomotor apraxia type 4, represent the extremes of an overlapping spectrum of disease. Cerebellar atrophy and elevated serum alpha-fetoprotein levels are early diagnostic findings across the entire phenotypical
spectrum
- …